Replies to post #11442 on Intellect Neurosciences Inc. (fka ILNS)

[john1045]

Nice post montanus and love the nice reference to ILNS!

Interesting candidates in ViroPharma's pipeline include maribavir for cytomegalovirus (CMV) infection and VP20629 for the treatment of Friedreich's Ataxia (FA). ViroPharma acquired VP20629 from Intellect Neurosciences, Inc. in Sep 2011.
ViroPharma generated revenues of $427.9 million in 2012.